132 related articles for article (PubMed ID: 17456923)
21. Cardiovascular effects of corticosteroid pulse therapy: a prospective controlled study on pemphigus patients.
Jain R; Bali H; Sharma VK; Kumar B
Int J Dermatol; 2005 Apr; 44(4):285-8. PubMed ID: 15811078
[No Abstract] [Full Text] [Related]
22. Long-term prognosis of pemphigus in central Kerala, India: a retrospective cohort study.
Ajithkumar K
Indian J Dermatol Venereol Leprol; 2014; 80(1):64-5. PubMed ID: 24448129
[No Abstract] [Full Text] [Related]
23. Cyclophosphamide-Induced Hearing Loss: Reversibility and Preventive Strategies.
Tuknayat A; Thami GP; Gogia P; Bhutani M
Am J Ther; 2018; 25(6):e692-e695. PubMed ID: 29232285
[No Abstract] [Full Text] [Related]
24. Dexamethasone pulse therapy: evidence for no benefit in pemphigus.
Jonkman MF
Indian J Dermatol Venereol Leprol; 2011; 77(2):190-1; author reply 191-2. PubMed ID: 21393952
[No Abstract] [Full Text] [Related]
25. Pemphigus in North-Western Yemen: A therapeutic study of 75 cases.
Khatri ML
Indian J Dermatol Venereol Leprol; 2016; 82(3):359. PubMed ID: 27088959
[TBL] [Abstract][Full Text] [Related]
26. Treatment of prurigo nodularis with dexamethasone-cyclophosphamide pulse therapy.
Gupta R
Indian J Dermatol Venereol Leprol; 2016; 82(2):239. PubMed ID: 26924412
[No Abstract] [Full Text] [Related]
27. Dexamethasone cyclophosphamide pulse therapy is highly efficient in autoimmune blistering and connective tissue disorders.
Manousaridis I; Utikal J; Goerdt S; Booken N
Eur J Dermatol; 2011; 21(1):129-30. PubMed ID: 21224179
[No Abstract] [Full Text] [Related]
28. Dexamethasone-cyclophosphamide pulse therapy for pemphigus.
Pasricha JS; Khaitan BK; Raman RS; Chandra M
Int J Dermatol; 1995 Dec; 34(12):875-82. PubMed ID: 8647673
[TBL] [Abstract][Full Text] [Related]
29. Dexamethasone-cyclophosphamide pulse therapy in systemic sclerosis: A retrospective study from a tertiary care hospital.
Dogra D; Dogra N; Gupta G; Mushtaq S
Indian J Dermatol Venereol Leprol; 2017; 83(4):494-496. PubMed ID: 28540872
[No Abstract] [Full Text] [Related]
30. Multiple autoimmune syndrome in a patient with pemphigus vulgaris.
Grandhe NP; Dogra S; Kanwar AJ
Acta Derm Venereol; 2005; 85(1):91-2. PubMed ID: 15849009
[No Abstract] [Full Text] [Related]
31. Intermittent high-dose dexamethasone-cyclophosphamide therapy for pemphigus.
Pasricha JS; Thanzama J; Khan UK
Br J Dermatol; 1988 Jul; 119(1):73-7. PubMed ID: 3408666
[TBL] [Abstract][Full Text] [Related]
32. [Comparative evaluation of the treatment of pemphigus with corticosteroids and corticosteroids combined with immunosuppressive agents].
Michałowski R; Kuczyńska L
Przegl Dermatol; 1981; 68(2):227-32. PubMed ID: 7029660
[No Abstract] [Full Text] [Related]
33. [Weekly cyclophosphamide pulse therapy combined with corticosteroids in the treatment of pemphigus].
Jia GQ; Chen ZQ; Li HL; Cui PG; Xu WY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):173-5. PubMed ID: 12905897
[TBL] [Abstract][Full Text] [Related]
34. Sulfasalazine and pentoxifylline, a new adjuvant in young pemphigus patients: A pilot study.
Dogra D; Dogra NK; Gupta N; Gupta V
Indian J Dermatol Venereol Leprol; 2015; 81(6):640-2. PubMed ID: 26515856
[No Abstract] [Full Text] [Related]
35. Dexamethasone-cyclophosphamide pulse therapy for autoimmune-vesiculobullous disorders at Victoria hospital, Bangalore.
Sacchidanand S; Hiremath NC; Natraj HV; Revathi TN; Rani S; Pradeep G; Tenneti V
Dermatol Online J; 2003 Dec; 9(5):2. PubMed ID: 14996375
[TBL] [Abstract][Full Text] [Related]
36. Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
Becker LR; Bastian BC; Wesselmann U; Karl S; Hamm H; Bröcker EB
Eur J Dermatol; 1998 Dec; 8(8):551-3. PubMed ID: 9889426
[TBL] [Abstract][Full Text] [Related]
37. [Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].
Appelhans M; Bonsmann G; Orge C; Bröcker EB
Hautarzt; 1993 Mar; 44(3):143-7. PubMed ID: 8463094
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of cyclophosphamide pulse therapy as an adjuvant to oral corticosteroid in the management of pemphigus vulgaris.
Sharma VK; Khandpur S
Clin Exp Dermatol; 2013 Aug; 38(6):659-64. PubMed ID: 23837939
[TBL] [Abstract][Full Text] [Related]
39. Corticosteroid/cyclophosphamide pulse treatment in South African patients with pemphigus.
Shaik F; Botha J; Aboobaker J; Mosam A
Clin Exp Dermatol; 2010 Apr; 35(3):245-50. PubMed ID: 19874327
[TBL] [Abstract][Full Text] [Related]
40. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
